Thursday, October 31, 2024

9:00 AM - 10:00 AM

Plenary Room

---

Details

Australia’s biotech and medtech landscape has long been defined by the presence of its two major anchors – Cochlear and CSL. Recent investments by both organisations show their ongoing commitment to supporting onshore commercialised research, enhanced manufacturing capability, and new partnerships to benefit our local ecosystem. These organisations are rightly, truly celebrated Australian success stories. But if they were starting out today, would their onshore trajectory be the same? In this intimate fireside session, AusBiotech’s CEO Rebekah Cassidy, speaks with two of Australia’s most senior medtech and biotech executives, Cochelar CEO, Dig Howitt, and CSL CFO, Joy Linton, about the opportunities they see to grow Australia’s life sciences ecosystem and what they believe industry and government need to change if we are to be successful in both developing and commercialising more innovative companies and strengthening the onshoring strategy for existing companies as part of a modernised future Australian economy.

---

Speaker